Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.
NCT ID: NCT06059053
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-01-12
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Semibranch Registry - Retrospective
NCT06374355
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
NCT05530304
Longitudinal Registry of Endovascular Thoracoabdominal Aneurysms
NCT03499431
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
NCT05195905
TOtal tRansfemoral branCHed endovasCular tHoracoabdominal Aortic Repair Registry
NCT04930172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Patency of the semibranch
* Feasibility of the technique regarding cannulation and stentgrafting
The participants will treated with the custom made semibranch device and enrolled in the registry if they consent. No change in treatment will be made when enrolled.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Semibranch CMD branched aortic stentgraft
bEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of pararenal or thoracoabdominal aortic pathology
* Treatment planned a semibranch device branch from Artivion
* Availability of the patients during the follow up period
* Informing patients about the study and providing written informed consent
Exclusion Criteria
* Patients under 18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Univ.-Prof. Dr. med. Alexander Oberhuber
Univ.-Prof. Dr. med. Alexander Oberhuber
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Oberhuber, MD,PhD
Role: STUDY_CHAIR
Department of Vascular and Endovascular Surgery University Hospital Münster
Alexander Oberhuber, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Vascular and Endovascular Surgery University Hospital Münster
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muenster University Hospital
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Semibranch_Reg
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.